Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK.
DevelRx Ltd, BioCity, Nottingham, UK.
Handb Exp Pharmacol. 2024;285:507-554. doi: 10.1007/164_2023_675.
Research into the involvement of adrenoceptor subtypes in the cause(s) of psychiatric disorders is particularly challenging. This is partly because of difficulties in developing animal models that recapitulate the human condition but also because no evidence for any causal links has emerged from studies of patients. These, and other obstacles, are outlined in this chapter. Nevertheless, many drugs that are used to treat psychiatric disorders bind to adrenoceptors to some extent. Direct or indirect modulation of the function of specific adrenoceptor subtypes mediates all or part of the therapeutic actions of drugs in various psychiatric disorders. On the other hand, interactions with central or peripheral adrenoceptors can also explain their side effects. This chapter discusses both aspects of the field, focusing on disorders that are prevalent: depression, schizophrenia, anxiety, attention-deficit hyperactivity disorder, binge-eating disorder, and substance use disorder. In so doing, we highlight some unanswered questions that need to be resolved before it will be feasible to explain how changes in the function of any adrenoceptor subtype affect mood and behavior in humans and other animals.
研究肾上腺素能受体亚型在精神障碍病因中的作用特别具有挑战性。部分原因是开发能够重现人类疾病的动物模型存在困难,此外,从患者研究中也没有出现任何因果关系的证据。这些以及其他障碍在本章中进行了概述。尽管如此,许多用于治疗精神障碍的药物在某种程度上与肾上腺素能受体结合。在各种精神障碍中,特定肾上腺素能受体亚型的功能的直接或间接调节介导了药物治疗作用的全部或部分。另一方面,与中枢或外周肾上腺素能受体的相互作用也可以解释其副作用。本章讨论了该领域的这两个方面,重点讨论了常见的疾病:抑郁症、精神分裂症、焦虑症、注意缺陷多动障碍、暴食障碍和物质使用障碍。在这样做的过程中,我们强调了一些未解决的问题,这些问题需要解决,然后才能解释任何肾上腺素能受体亚型功能的变化如何影响人类和其他动物的情绪和行为。